R&D Agentic AI and the human element: Building trustworthy autom... The future of clinical trials isn’t about replacing people. It’s about empowering them with smarter tools.
R&D Simplicity wins: How Lean principles and smart automation ca... Manufacturers truly outperforming their peers share a defining trait: a ruthless commitment to simplicity, based on Lean principles and automation.
Digital Beyond regulation: 4 AI trends transforming life sciences te... Artificial intelligence (AI) is becoming embedded into the fabric of quality, compliance, and production systems.
Digital 2026: When clinical intelligence moves from promise to pract... We are about to enter a new era of clinical intelligence. The era of "digital" as a separate activity in healthcare will begin to dissolve in 2026.
Sales & Marketing The hidden IP problem holding innovators back For organisations active in the US market, the impact of patent marking is financial, not administrative.
News Novartis snaps up PI3Kα breast cancer drug in $3bn deal Novartis has agreed to buy a PI3Kα-targeting drug for breast cancer from Synnovation, a potential successor to its Piqray brand, for $2bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
